FDA Approves Controversial New Alzheimer’s Drug

Lecanemab shows clinical benefits — but do they justify the risks?

By Kenneth Miller
Dec 12, 2023 11:00 PM
GettyImages-1296945064 (1)
More than 6 million Americans are living with Alzheimer’s disease. By 2050, that figure may surge to nearly 13 million. (Credit: PamelaJoeMcFarlane/E+ VIA Getty Images)

Newsletter

Sign up for our email newsletter for the latest science news
 

Few ailments are as fearsome as Alzheimer’s disease, the most common form of dementia, which robs patients of their minds and memories before it takes their lives. So, when the U.S. Food and Drug Administration approved a new treatment for Alzheimer’s in July, the event made front-page news. But it also generated heated arguments.

What Is the New Alzheimer's Drug?

0 free articles left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

0 free articlesSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!

Subscribe

Already a subscriber?

Register or Log In

Stay Curious

Sign up for our weekly newsletter and unlock one more article for free.

 

View our Privacy Policy


Want more?
Keep reading for as low as $1.99!


Log In or Register

Already a subscriber?
Find my Subscription

More From Discover
Recommendations From Our Store
Shop Now
Stay Curious
Join
Our List

Sign up for our weekly science updates.

 
Subscribe
To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2024 Kalmbach Media Co.